This increased secretion could elicit neovascularisation in breast cancer [5,12] and could also contribute to the M1 to M2 switch, since M-CSF-treated monocytes express a substantial part of the M2 transcriptome [51]. The gene discussed is CSF1; the disease is breast carcinoma.